id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-4403-0001,FDA,FDA-2018-E-4403,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2018-11-19T05:00:00Z,2018,11,2018-11-19T05:00:00Z,,2018-11-19T13:01:13Z,,0,0,09000064838e2d50
FDA-2018-E-4403-0002,FDA,FDA-2018-E-4403,Patent Extension Application from Intellectual Property and Litigation (on behalf of Amgen Inc.),Other,Application,2018-11-19T05:00:00Z,2018,11,2018-11-19T05:00:00Z,,2018-11-19T13:07:33Z,,0,0,09000064838e6dfd